Market Data
News
Tools
Markets
Discover
Subscribe Login/Register
S&P ASX 200
7,091.30
(
-1.64%
)
S&P ASX All Technology
2,373.40
(
-0.51%
)
Brent Oil
72.015
(
-2.44%
)
US Dollar vs AUD
1.54408
(
0.65%
)
Bitcoin
27,069.14
(
-2.28%
)
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Acadia Pharmaceuticals Inc (ACAD)

  7. Acadia Pharmaceuticals Inc (ACAD) Financials

ACAD

Acadia Pharmaceuticals Inc

23.79
0.00 (0.0%)
Upgrade to Real-Time

ACADIA Pharmaceuticals Inc. (ACAD) Fundamentals
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
SHARE INFORMATION
Market CapUS$ 3,868,857,766
Shares Outstanding162,625,379
Float123,346,090
Percent Float75.85%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 118,462,000
Latest Fiscal EPSUS$ -0.27
Latest Fiscal Date2023-03-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions579
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months13,537,034
Institutional Holdings Percent138.3%
Institutional Sold Previous 3 Months12,786,865
Insider Holdings Date2023-03-31
Insider Bought Previous 3 Months221,406
Insider Holdings Percent142.4
Insider Sold Previous 3 Months229,800
Insider Shares Owned231,033,957
TRADING INFO
52 Week HighUS$ 26.04
52 Week LowUS$ 12.24
52 Week High ChangeUS$ 39.29
21 Day Moving AverageUS$ 22.7833
21 Day Extended Moving AverageUS$ 22.986
50 Day Moving AverageUS$ 20.6518
50 Day Extended Moving AverageUS$ 21.4329
200 Day Moving AverageUS$ 18.0193
200 Day Extended Moving AverageUS$ 19.2396
10 Day Average Volume1,675,896
20 Day Average Volume1,533,971
30 Day Average Volume1,402,190
50 Day Average Volume1,377,895
Alpha0.011774
Beta0.5378
Standard Deviation0.152044
R20.036172
7 Day Price ChangeUS$ -1.75
7 Day Percent Change-6.85%
21 Day Price ChangeUS$ 2.36
21 Day Percent Change11.01%
30 Day Price ChangeUS$ 2.46
30 Day Percent Change11.53%
Month to Date Price ChangeUS$ 2.46
Month to Date Percent Change11.53%
Quarter to Date Price ChangeUS$ 4.97
Quarter to Date Percent Change26.41%
180 Day Price ChangeUS$ 8.21
180 Day Percent Change52.7%
200 Day Price ChangeUS$ 7.40
200 Day Percent Change45.15%
Year to Date Price ChangeUS$ 7.87
Year to Date Percent Change49.43%

ACADIA Pharmaceuticals Inc. (ACAD) Key Ratios

PROFITABILITY
EBIT Margin-30.3%
EBITDA Margin-30.8%
Pre-Tax Profit Margin-54.5%
Profit Margin Count-0.36%
Gross Margin98.3%
Profit Margin TOT-0.36%
INCOME STATEMENTS
RevenueUS$ 118,462,000
Revenue Per ShareUS$ 0.7284
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book13.50
Total Debt To Equity0.10
Int Coverage0.00
Current Ratio2.30
Leverage Ratio1.80
Quick Ratio2.10
Long Term Debt To Capital0.12
VALUATION MEASURES
PE Ratio0.00
Enterprise ValueUS$ 3,800,925,180
Price to Sales7.75
Price to Free Cash0.00
PE High Last 5 Years0.00
Price To Book10.90
Price To Cash Flow-56.20
PE Low Last 5 Years0.00
Price to Tangible Book13.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover8.10
Invoice Turnover1.50
Assets Turnover0.80
Return Assets-22.91
Return on Equity-35.86
Return on Capital-33.79

ACADIA Pharmaceuticals Inc. (ACAD) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
Auditor-
CEOStephen R. Davis
Employees540
Last Audit-
CIK0001070494
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address12830 El Camino Real,Suite 400
Suite 400
San Diego, CA 92130
Websitehttps://www.acadia-pharm.com
Facsimile+1 858 212-0513
Telephone+1 858 558-2871
Emailir@acadia-pharm.com
Your Recent History
NASDAQ
ACAD
Acadia Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: au D: 20230531 11:21:48